Status:
UNKNOWN
The Impact Of Tissue Micro-RNA Profile From EUS-FNA In Pancreatic Adenocarcinoma
Lead Sponsor:
Carol Davila University of Medicine and Pharmacy
Collaborating Sponsors:
Bucharest Emergency Hospital
Institutul Clinic Fundeni
Conditions:
Pancreatic Adenocarcinoma
Eligibility:
All Genders
18+ years
Brief Summary
Pancreatic adenocarcinoma still represents one of the "hot-topics" worldwide. Endoscopic ultrasonography was a breakthrough, bringing us closer to personalized treatment by getting histopathological s...
Eligibility Criteria
Inclusion
- Pancreatic solid mass, with or without a cystic component
- Age over 18 years old
- Signed informed consent
Exclusion
- Cystic pancreatic mass with no solid component
- Abnormal coagulation (elevated INR \>1.5, thrombocytopenia\<60 000/mm3, activated partial thromboplastin time\>42 seconds), participant on anticoagulant treatment that cannot stop the treatment
- European Cooperative Oncology Group status 4
- Pregnancy
- Age under 18 years old
- The participant does not want to sign the consent form, or is unable to
- Difficult puncture position during endoscopic ultrasonography: vessels or Wirsung duct positioned in front of the needle (decision of the endoscopist)
Key Trial Info
Start Date :
March 21 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 1 2021
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT04765410
Start Date
March 21 2019
End Date
June 1 2021
Last Update
February 21 2021
Active Locations (5)
Enter a location and click search to find clinical trials sorted by distance.
1
"Carol Davila" University Central Emergency Hospital
Bucharest, Sector 1, Romania, 010825
2
"Prof Dr Agrippa Ionescu" Emergency Hospital
Bucharest, Sector 1, Romania, 011356
3
Clinical Emergency Hospital Bucharest
Bucharest, Sector 1, Romania, 014461
4
Fundeni Clinical Institute
Bucharest, Sector 2, Romania, 022328